Log in
Enquire now
PreciThera

PreciThera

PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases.

OverviewStructured DataIssuesContributors

Contents

precithera.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Location
Canada
Canada
B2X
B2C
B2C
CEO
Pierre Beauparlant
Pierre Beauparlant
Founder
Philippe Crine
Philippe Crine
Susan Schiavi
Susan Schiavi
Pitchbook URL
pitchbook.com/profiles...181959-04
Legal Name
PreciThera, Inc.
Legal classification
Corporation
Corporation
Number of Employees (Ranges)
1 – 10
Full Address
1010 Sherbrooke Street West Suite 408 Montreal, Quebec H3A 2R7 Canada
Investors
Arix Bioscience plc
Arix Bioscience plc
CTI Life Sciences Fund
CTI Life Sciences Fund
Fonds de solidarité FTQ
Fonds de solidarité FTQ
Sanderling
Sanderling
‌
Emerillon Capital
Sanderling Ventures
Sanderling Ventures
Founded Date
2016
0
Total Funding Amount (USD)
29,000,000
Latest Funding Round Date
July 27, 2017
Latest Funding Type
Series A
Series A
Country
Canada
Canada

Other attributes

Company Operating Status
Active

PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases, leveraging the application of computational technology and disease pathology. It focuses on diverse genetic disorders that appears in bone dysfunction.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like PreciThera

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.